(Q30827854)

26 June 2017

title

Attenuation of bone mass and increase of osteoclast formation in decoy receptor 3 transgenic mice (English)

1 reference

26 June 2017

Wen-Mei Fu

7

0 references

Rong-Sen Yang

object named as

Rong-Sen Yang

5

0 references

author name string

Chih-Hsin Tang

1

1 reference

26 June 2017

Tsui-Ling Hsu

2

1 reference

26 June 2017

Wan-Wan Lin

3

1 reference

26 June 2017

Ming-Zong Lai

4

1 reference

26 June 2017

Shie-Liang Hsieh

6

1 reference

26 June 2017

language of work or name

English

0 references

publication date

10 November 2006

1 reference

Journal of Biological Chemistry

26 June 2017

published in

1 reference

26 June 2017

volume

282

1 reference

26 June 2017

issue

4

1 reference

26 June 2017

page(s)

2346-2354

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

26 June 2017

1 reference

Bone resorption by osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

Therapeutic approaches to bone diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

Cell biology of the osteoclast

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

The effect of macrophage-colony stimulating factor and other humoral factors (interleukin-1, -3, -6, and -11, tumor necrosis factor-alpha, and granulocyte macrophage-colony stimulating factor) on human osteoclast formation from circulating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

Selective induction of tumor necrosis receptor factor 6/decoy receptor 3 release by bacterial antigens in human monocytes and myeloid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

Soluble decoy receptor 3 induces angiogenesis by neutralization of TL1A, a cytokine belonging to tumor necrosis factor superfamily and exhibiting angiostatic action

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

Enhanced adhesion of monocytes via reverse signaling triggered by decoy receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

Attenuation of Th1 response in decoy receptor 3 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

Prostaglandin E2 stimulates fibronectin expression through EP1 receptor, phospholipase C, protein kinase Calpha, and c-Src pathway in primary cultured rat osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

Enhancement of fibronectin synthesis and fibrillogenesis by BMP-4 in cultured rat osteoblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

Molecular mechanisms of cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

Ultrasound stimulates cyclooxygenase-2 expression and increases bone formation through integrin, focal adhesion kinase, phosphatidylinositol 3-kinase, and Akt pathway in osteoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603070200

21 January 2018

Identifiers

DOI

10.1074/JBC.M603070200

1 reference

26 June 2017

1 reference